An international team led by the Universities of Geneva and Marburg has discovered that D-cysteine — a mirror-image version of the naturally occurring amino acid cysteine — can dramatically slow cancer growth while sparing healthy cells. The molecule enters cancer cells through a specific transporter found only on certain tumor surfaces and blocks the NFS1 enzyme in mitochondria, cutting off iron-sulfur cluster production essential for cellular respiration and DNA synthesis.

In mice with aggressive mammary tumors, D-cysteine treatment significantly slowed tumor progression with minimal side effects. "D-Cys is imported into cells via a specific transporter that is present only on certain cancer cells," said Joséphine Zangari, first author of the study. The findings, published in Nature Metabolism, open a potential new pathway for targeted cancer therapy, though human clinical trials are still needed to confirm safety and efficacy.